definiens: ) plus any Third Party Payments ( as defined below ), TM shall, in each case to the extent directly related to the subject matter of the [COMPANY] P atents and/or [COMPANY] Know - How in the Field, A ) provide [COMPANY] with copies of any existing TM Know - how, preclinical and clinical data, assays and associated materials, and protocols and procedures, B ) grant, and hereby is deemed to grant, a non - exclusive license to [COMPANY] to use, sell, manufacture, offer for sale, import and export products containing IGF - I under any TM Patents or TM Know - how, C ) allow [COMPANY] to cross - reference any INDs, BLAs, clinical data or other submissions filed with the F DA and provide [COMPANY] with copies of any FDA Documentation, and D ) grant [COMPANY] exclusive rights to use any Trademarks filed in connection with any Licensed Products, to the extent such Trademarks ar e specific to one or more such Licensed Products and not generally associated with any other product of TM ( or its Affiliates or their sublicensees ) or containing an element of the TM tradename, in each case solely for purposes of using, selling, offerin g for sale, importing or exporting such products cont aining IGF - I in the Territory . To the extent TM is obligated to pay any amounts to a Third Party under any TM Patents which are licensed to TM by, or co - owned by, such Third Party based on [COMPANY] ’s exerci se of any of the foregoing rights, [COMPANY] shall be solely responsible for such royalties ( collectively, ) . For all sales of product for which a Third Party Payment is due, the TM Royalty shall be reduced by [ * ] of the Third Party Payment due with respect to such sales ; provided ho wever, that in no event shall * This provision is the subject of a Confidential Tre atment Request